Peer Review History
| Original SubmissionNovember 21, 2019 |
|---|
|
PONE-D-19-32407 Potential endocrine disrupting properties of toys for babies and infants PLOS ONE Dear Mr. Rousselle, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. We would appreciate receiving your revised manuscript by Mar 13 2020 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols Please include the following items when submitting your revised manuscript:
Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. We look forward to receiving your revised manuscript. Kind regards, Shanaz Hashmi Dairkee, Ph.D. Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements: 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at http://www.plosone.org/attachments/PLOSOne_formatting_sample_main_body.pdf and http://www.plosone.org/attachments/PLOSOne_formatting_sample_title_authors_affiliations.pdf 2. Please amend your manuscript to include your abstract after the title page. 3. Thank you for stating the following in your Competing Interests section: "No" Please complete your Competing Interests on the online submission form to state any Competing Interests. If you have no competing interests, please state "The authors have declared that no competing interests exist.", as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now This information should be included in your cover letter; we will change the online submission form on your behalf. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: N/A Reviewer #2: N/A ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The topic of the manuscript is of high relevance. The data are worth to be published, although some questions remain open. In the Chapter "Conclusions" is mentioned for the first time in the manuscript that BPA might not come from the investigated parts of toys, but also from the packaging (recycled cardboard boxes) and transportation. This opens the question why package material has not been investigated in this study to provide evidence for this speculation. At least citations related to this aspect should be implemented, i.e. Vandermarken et al. (2019): Chemosphere 221, 99-106 and references cited in there. The desriptiom of the chemical analytical methods is insufficient and should be extended (see several remarks in the attrached file). It is refered to a previous publication (Mertl et al. (2014) in Plos-one). But in this publication many analytical details are also missing. Recovery rates for the quantified compounds have to be implemented in one table and it should be mentioned whether recoveries have been considered for calculation of the quantities. I am astonished about the high values for detection limits and quantitation limits (in the µg/L ranges). The authors should explain why the limits are so bad in comparion to other studies using the same or similar analytical methods. The data used for Figure 2 have to be presented in detail. Some recent publications dealing with this topic have not been considered but should be considered. Szczepańska N., Namieśnik J., Kudłak B. (2016): Assessment of toxic and endocrine potential of substances migrating from selected toys and baby products. Environmental Science and Pollution Research 23, 24890-24990. Asimakopoulos A.G., Elangovan M., Kannan K., (2016): Migration of Parabens, Bisphenols, Benzophenone-Type UV Filters, Triclosan, and Triclocarban from Teethers and Its Implications for Infant Exposure. Environmental Science and Technology 50, 13539-13547. Potouridis T. Knauz A., Berger E. & Püttmann W. (2019): Examination of paraben release from baby teethers through migration tests and GC–MS analysis using a stable isotope dilution assay. BCM Chemistry 13, 70. https://doi.org/10.1186/s13065-019-0587-6 and references cited in there. Additonal comments are provided in the attached file. Reviewer #2: Reviewer comments: This study was designed to evaluate potential endocrine disrupting properties of toys for babies and infants by using in vitro cell-based reporter gene assays detecting ER and AR agonist and antagonist combined with chemical analysis. Authors clearly indicated that 9 out of 18 tested toys showed significant ER agonist activity. Among them, the detected ER agonist activity could be well explained by well-known EDC “BPA” for two samples. However, for seven samples, ER agonists, which strongly contribute to detected activity, could not be identified. Exposure assessment based on the worst-case scenarios suggest that BPA-containing toys could be above the temporary TDI. Topic is very important and meaningful. However, there are several concerns in this manuscript. After revisions according to the following comments, manuscript will be accepted in PLOS ONE. 1. Abstract – I think authors had better describe about existence of unidentified ER agonists in toys in this section because they must be important on the toxicological point of view. I think that unidentified/unrevealed ER agonists are more important than BPA detected in this study. Although BPA will phase out, unidentified/unrevealed ER agonists might be emerging contaminants. Related to this point, authors should try to think and state importance of using in vitro bioassay detecting EDC. In vitro bioassay is not mere screening method and must be useful hazard detection method. 2. Materials and Methods, 1.1. Selection of toys, line 115 – Table 2 is Table 1? 3. Materials and Methods, 1.5. Chemical trace analysis, line 185 to 189 – Authors had better state why you measured these 41 known or suspected endocrine substances as well as common alternatives to endocrine active plasticizers in not only the text but also Table 1. Related laws or regulations are very welcome and must be useful for reader to understand importance of this study. 4. Materials and Methods, 1.7. Assessment of the health risks associated with the mouthing of plastic toys containing phthalate substitutes, line 243 to 246 – Authors should indicate “BW”, “F”, “S”, and “D” used in this study in the section of results and discussion by using Table or Supporting Information. 5. Results and discussion, Table 3 – Authors should indicate LOD with a figure for “Anti-estrogen activity” and “Anti-androgen activity”. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 1 |
|
Potential endocrine disrupting properties of toys for babies and infants PONE-D-19-32407R1 Dear Dr. Rousselle, We are pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it complies with all outstanding technical requirements. Within one week, you will receive an e-mail containing information on the amendments required prior to publication. When all required modifications have been addressed, you will receive a formal acceptance letter and your manuscript will proceed to our production department and be scheduled for publication. Shortly after the formal acceptance letter is sent, an invoice for payment will follow. To ensure an efficient production and billing process, please log into Editorial Manager at https://www.editorialmanager.com/pone/, click the "Update My Information" link at the top of the page, and update your user information. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, you must inform our press team as soon as possible and no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. With kind regards, Shanaz Hashmi Dairkee, Ph.D. Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-19-32407R1 Potential endocrine disrupting properties of toys for babies and infants Dear Dr. Rousselle: I am pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. For any other questions or concerns, please email plosone@plos.org. Thank you for submitting your work to PLOS ONE. With kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Shanaz Hashmi Dairkee Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .